Recursion Pharmaceuticals EBIT Margin

EBIT Margin (Operating Margin) of Recursion Pharmaceuticals is -867.87 % in 2026.

EBIT Margin (Operating Margin) of Recursion Pharmaceuticals changed from -814.09 % to -867.87 %, representing a 6.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Recursion Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Recursion Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).